Literature DB >> 11215995

Stability of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in fresh blood and plasma and postmortem blood samples.

G Skopp1, L Pötsch, A Klingmann, R Mattern.   

Abstract

The present study was designed to determine the stability of morphine and its glucuronides in spiked fresh blood and plasma from live individuals as well as in four authentic postmortem blood specimens for a time interval of up to six months. The samples were stored in glass vials at -20 degrees C, 4 degrees C, and 20 degrees C. Additionally, spiked samples were exposed to light through window glass and subjected to a forced-degradation study at 40 degrees C. Data were established using solid-phase extraction and high-performance liquid chromatography coupled to atmospheric pressure ionization mass spectrometry for isolation and quantitation, providing a sensitive and specific detection method for the parent drug in the presence of its glucuronide metabolites. Morphine and its glucuronide metabolites were found to be stable in both blood and plasma at 4 degrees C for the whole observation period. In postmortem blood the analytes were stable only when stored at -20 degrees C. The thermal decomposition of morphine and morphine-6-glucuronide in spiked blood and plasma could be interpreted using pseudo first-order kinetics. Photodegradation of morphine-3-glucuronide in plasma was consistent with a second-order reaction. In postmortem samples the degradation pattern differed completely from that observed in fresh blood and plasma. The elevated morphine levels observed were primarily due to postmortem hydrolysis of morphine glucuronides.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11215995     DOI: 10.1093/jat/25.1.2

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  8 in total

Review 1.  Post-mortem clinical pharmacology.

Authors:  R E Ferner
Journal:  Br J Clin Pharmacol       Date:  2008-05-29       Impact factor: 4.335

Review 2.  The influence of putrefaction and sample storage on post-mortem toxicology results.

Authors:  Danielle M Butzbach
Journal:  Forensic Sci Med Pathol       Date:  2009-11-28       Impact factor: 2.007

3.  Long-term tracking of opioid consumption in two United States cities using wastewater-based epidemiology approach.

Authors:  Adam J Gushgari; Arjun K Venkatesan; Jing Chen; Joshua C Steele; Rolf U Halden
Journal:  Water Res       Date:  2019-06-03       Impact factor: 11.236

4.  Postmortem redistribution of the heroin metabolites morphine and morphine-3-glucuronide in rabbits over 24 h.

Authors:  Peter D Maskell; Mohammed Albeishy; Giorgia De Paoli; Nathan E Wilson; L Nitin Seetohul
Journal:  Int J Legal Med       Date:  2015-04-12       Impact factor: 2.686

5.  Stability of ethyl glucuronide in urine, post-mortem tissue and blood samples.

Authors:  Haiko Schloegl; Sebastian Dresen; Karin Spaczynski; Mylène Stoertzel; Friedrich Martin Wurst; Wolfgang Weinmann
Journal:  Int J Legal Med       Date:  2005-07-30       Impact factor: 2.686

6.  Time-dependent postmortem redistribution of morphine and its metabolites in blood and alternative matrices-application of CT-guided biopsy sampling.

Authors:  Sandra N Staeheli; Dominic Gascho; Lars C Ebert; Thomas Kraemer; Andrea E Steuer
Journal:  Int J Legal Med       Date:  2016-12-03       Impact factor: 2.686

7.  Codeine accumulation and elimination in larvae, pupae, and imago of the blowfly Lucilia sericata and effects on its development.

Authors:  Hicham Kharbouche; Marc Augsburger; Daniel Cherix; Frank Sporkert; Christian Giroud; Claude Wyss; Christophe Champod; Patrice Mangin
Journal:  Int J Legal Med       Date:  2007-12-07       Impact factor: 2.686

8.  The feasibility of physiologically based pharmacokinetic modeling in forensic medicine illustrated by the example of morphine.

Authors:  Nadine Schaefer; Daniel Moj; Thorsten Lehr; Peter H Schmidt; Frank Ramsthaler
Journal:  Int J Legal Med       Date:  2017-12-01       Impact factor: 2.686

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.